Skip to main content
Top
Published in:

20-05-2025 | Neurointensive Care | Review Free for a limited time

Transport of the Neurocritical Care Patient

Authors: Vasisht Srinivasan, Neha S. Dangayach

Published in: Current Treatment Options in Neurology | Issue 1/2025

Login to get access

Abstract

Purpose of Review

This review aims to summarize the special considerations and gaps in the literature to inform evidence- based practices for the transport of neurologically critically ill patients.

Recent Findings

Neurologically critically ill patients may need to undergo interhospital transfers (IHT) for a variety of reasons, including access to monitoring, definitive management, higher levels of care, as part of a systems of care approach, family request, or continuity of care. With increasing regionalization of care for stroke, trauma, and cardiac arrest, more patients will require IHT for their care. In addition to the clinical parameters that need to be monitored while transporting any critically ill patient (e.g. airway, hemodynamic data, infusions, blood product transfusions, etc.), special considerations in neurologically critically ill patients during IHT include the management of intracranial hypertension, cerebral edema, seizures, spine stability, and offloading of cranial defects and wounds.

Summary

Neurologically critically ill patients have numerous details that need to be addressed during transport that make them a unique population. Careful monitoring and aggressive treatment of hemodynamics, airway, mechanical ventilation, intracranial hypertension, seizures, and prevention of secondary neurological injuries while undergoing IHT is critical to ensuring a good outcome for patients.
Literature
This content is only visible if you are logged in and have the appropriate permissions.
Metadata
Title
Transport of the Neurocritical Care Patient
Authors
Vasisht Srinivasan
Neha S. Dangayach
Publication date
20-05-2025

EAN 2025

Unlock your free and exclusive access to the latest news and expert interviews from the European Academy of Neurology's annual congress.

Read more

How can your team use biomarkers to improve management of AD? (Link opens in a new window)

Our experts explore using biomarker tests and interpreting results, establishing a shared decision-making approach with patients and caregivers, and applying biomarker testing to guide treatment strategies.

This content is intended for healthcare professionals outside of the UK.

Supported by:
  • Lilly
Developed by: Springer Health+ IME
Register your interest